chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Post-acute COVID-19 syndrome
Clinical narrative: Long COVID; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. Other Case identifier(s): MOD-2023-729253 (Moderna).  A 69-year-old female patient received BNT162b2 (BNT162B2), on 05Mar2021 as dose 1, single (Lot number: EN6203), on 26Mar2021 as dose 2, single (Lot number: ER2613) and on 15Oct2021 as dose 3 (booster), single (Lot number: FF8814) at the age of 67 years for covid-19 immunisation. The patient's relevant medical history included: "asthma" (ongoing), notes: Treatment: Symbicort; "allergies" (unspecified if ongoing); "arthritis" (unspecified if ongoing); "BP/Blood pressure" (unspecified if ongoing), notes: fairly under control; "depression" (ongoing), notes: treated for depression which is working very well. The patient's concomitant medications were not reported. Past drug history included: Symbicort for asthma, notes: She has asthma and is on Symbicort, which keeps her lungs under good condition;. The following information was reported: POST-ACUTE COVID-19 SYNDROME (non-serious), outcome "not recovered", described as "Long COVID". Therapeutic measures were taken as a result of post-acute covid-19 syndrome.  Additional Information: The 1st 3 doses were Pfizer and she claimed that she did not get relief of her long Covid symptoms. Patient had also received Moderna on 22Apr2022 as dose 4, single (Lot number: 001M21A) and on 19Oct2022 as dose 5, single (Lot number: AS7164B) for covid-19 immunisation and claimed that she was symptom free for at least 6 weeks after getting the doses. Patient had also received other vaccines in the 4 weeks prior to COVID-19 vaccine. Patient stated that she contracted Covid-19 in Mar2020 before she received the 1st dose of the Covid-19 vaccine which led to her having long Covid. The symptoms she mentioned were fever and fatigue. She had been pretty much sick for 13 months. She stated that she would be pretty lucky if she had 4 days symptom free but symptoms mentioned come back. The symptoms would also appear when she was under a lot of stress like at the time of the call where she had now been taking Dayquil for 3-4 days. She was losing a lot of time at work.
Sex: U
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Drug ineffective, SARS-CoV-2 test
Clinical narrative: Positive test for SARS-Cov2; Positive test for SARS-Cov2; This is a spontaneous report received from a contactable reporter(s) (Pharmacist).  A 79-year-old patient received BNT162b2 (BNT162B2), as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Drug allergies: Penicillin" (unspecified if ongoing); "AF/ Atrial fibrillation" (unspecified if ongoing); "T2DM/ Type 2 diabetes mellitus" (unspecified if ongoing); "HTN/Hypertension" (unspecified if ongoing); "high cholesterol" (unspecified if ongoing); "neuropathy" (unspecified if ongoing); "Heart disease" (unspecified if ongoing); "Obesity" (unspecified if ongoing); "sepsis" (unspecified if ongoing), notes: sepsis requiring ventilation in Sep2022; "ventilation", start date: Sep2022 (unspecified if ongoing), notes: sepsis requiring ventilation in Sep2022; "non-smoker " (unspecified if ongoing); "No alcohol" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (hospitalization, medically significant), COVID-19 (hospitalization, medically significant) all with onset Apr2023, outcome "recovered" (2023) and all described as "Positive test for SARS-Cov2". The patient was hospitalized for drug ineffective, covid-19 (start date: 28Apr2023, discharge date: 02May2023, hospitalization duration: 5 day(s)). The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (Apr2023) Positive, notes: over the counter Nasal swab; (28Apr2023) Negative, notes: tested negative in hospital; (02May2023) Negative. Therapeutic measures were taken as a result of drug ineffective, covid-19.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: The vaccine efficacy varies from one patient to another and can be affected by different factors; however, a contributory role of the suspect vaccine BNT162B2 to the Drug ineffective and COVID-19 cannot be ruled out.,Linked Report(s) : US-PFIZER INC-PV202300078346 same reporter/patient,different drug/AE;
Sex: F
Vaccine: COVID19
Symptoms: Gene mutation, Loss of consciousness
Clinical narrative: started passing out randomly and said that she's been experiencing them too; the vaccines changed her DNA composition and her DNA molecular structure; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP), Program ID. The reporter is the patient.  A female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: LOSS OF CONSCIOUSNESS (medically significant), outcome "unknown", described as "started passing out randomly and said that she's been experiencing them too"; GENE MUTATION (non-serious), outcome "unknown", described as "the vaccines changed her DNA composition and her DNA molecular structure". Clinical course: Caller wanted to know the chemical composition of the Pfizer Covid-19 Vaccine. Caller wanted to know why the vaccines were not yet approved by the FDA. She stated that she had been experiencing some serious side effects after the vaccine. She said that she started passing out randomly. She wanted to know if Pfizer employees were experiencing them too or if even Pfizer employees took the Pfizer Covid-19 vaccines. Caller also was not sure if she was going to live for another three or five years because of the vaccines because she said that the vaccines changed her DNA composition and her DNA molecular structure. She said that the vaccines gave her a third helix on her DNA.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-PV202300108344 same reporter and drug, different patient and event;
Sex: F
Vaccine: COVID19
Symptoms: Headache, Loss of consciousness, Near death experience
Clinical narrative: Almost died; Passed out; Headache problems; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP), Program ID.  A female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: NEAR DEATH EXPERIENCE (medically significant), outcome "unknown", described as "Almost died"; LOSS OF CONSCIOUSNESS (medically significant), outcome "unknown", described as "Passed out"; HEADACHE (non-serious), outcome "unknown", described as "Headache problems". Clinical course: Reporter stated that her grandma passed out and almost died. She said that her grandma had headache problems and started passing out randomly.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-PV202300108339 same reporter/drug, different patient/event;
Sex: U
Vaccine: MEN
Symptoms: Accidental exposure to product, Medication error, No adverse event
Clinical narrative: the vial cut finger of staff member when removing from carton with no repoted adverse event; Initial information was received on 15-Jun-2023 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves an unknown age and unknown gender patient who reported that the vial cut finger of staff member when removing from carton with no repoted adverse event after receiving vaccine meningococcal a-c-y-w135 (t conj) vaccine [Menquadfi].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On an unknown date, the patient received a unknown dose of suspect meningococcal a-c-y-w135 (t conj) vaccine (Solution for injection) (lot U7584AD) (strength, expiry date unknown) via unknown route in unknown administration site for prophylactic vaccination(Immunization).  On an unknown date the patient developed a non-serious event of the vial cut finger of staff member when removing from carton with no repoted adverse event (accidental exposure to product) (unknown latency) following the administration of meningococcal a-c-y-w135 (t conj) vaccine.  Action taken with meningococcal vaccine (Menquadfi) was not applicable.  At time of reporting, the outcome was Unknown for the event the vial cut finger of staff member when removing from carton with no repoted adverse event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 11.0
Sex: F
Vaccine: COVID19, UNK
Symptoms: ALK gene rearrangement positive, Anaplastic lymphoma kinase gene mutation, COVID-19, Gene mutation identification test positive, Inflammatory myofibroblastic tumour
Clinical narrative: Patient received Covid vaccine L deltoid on 11/12/21 and 12/3/21.  Had covid illness in early May 2022.  Shortly thereafter noticed lump in left upper arm.
Age: 11.0
Sex: F
Vaccine: COVID19, UNK
Symptoms: Injection site mass, Magnetic resonance imaging abnormal, Spindle cell sarcoma, X-ray limb normal
Clinical narrative: Patient received Covid vaccine L deltoid on 11/12/21 and 12/3/21.  Had covid illness in early May 2022.  Shortly thereafter noticed lump in left upper arm.
Sex: U
Vaccine: VARZOS
Symptoms: Illness
Clinical narrative: was sick/ very sick; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of sickness in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced sickness (Verbatim: was sick/ very sick). The outcome of the sickness was resolved (duration 3 weeks).   It was unknown if the reporter considered the sickness to be related to Shingles vaccine.     It was unknown if the company considered the sickness to be related to Shingles vaccine.   Additional Information: GSK receipt date: 13-JUN-2023 This case was reported by a patient via interactive digital media. The patient was very sick after the shingles shot and had to go to urgent care. The reporter reported that to contact him/her.
Sex: F
Vaccine: VARZOS
Symptoms: Pain in extremity
Clinical narrative: just some arm pain/ arm hurt some the first shot; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of pain in arm in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Family history included shingles (husband and younger sister had them).   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced pain in arm (Verbatim: just some arm pain/ arm hurt some the first shot). The outcome of the pain in arm was not reported.   It was unknown if the reporter considered the pain in arm to be related to Shingles vaccine.     It was unknown if the company considered the pain in arm to be related to Shingles vaccine.   Linked case(s) involving the same patient:  US2023AMR084836   Additional Information: GSK receipt date: 14-jun-2023 This case was reported by a patient via interactive digital media. The patient reporter that she had her first shot and was good just some arm pain and no others affect.  The follow-up could not be possible as no contact details were available. For tolerance of 2nd dose, refer case US2023AMR084836, reported by same reporter.; Sender's Comments:  US-GSK-US2023AMR084836:Same patient/second shingles shot
Sex: U
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event
Clinical narrative: No adverse event; 5 patients were administered an expired vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (5 patients were administered an expired vaccine) and NO ADVERSE EVENT (No adverse event) in a  patient of an unknown age and gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 041H22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 12-Jun-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 12-Jun-2023,  after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced EXPIRED PRODUCT ADMINISTERED (5 patients were administered an expired vaccine). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (5 patients were administered an expired vaccine) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (5 patients were administered an expired vaccine).    No concomitant medication  was provided. No treatment medication were provided. This case contain information of 5th patient out of 5th reported by reporter.   This case was linked to US-MODERNATX, INC.-MOD-2023-728837 (E2B Linked Report).   Reporter did not allow further contact; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-728837:Master Case
Sex: U
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event
Clinical narrative: No adverse event; 5 patients were administered an expired vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (5 patients were administered an expired vaccine) and NO ADVERSE EVENT (No adverse event) in a  patient of an unknown age and gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 041H22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 12-Jun-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 12-Jun-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (5 patients were administered an expired vaccine). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (5 patients were administered an expired vaccine) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (5 patients were administered an expired vaccine).    No concomitant medication was reported. Dosage text for suspect product was reported as unknown. No treatment medication was reported. This case corresponds to 2nd out of 5 patients as described by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2023-728837 (E2B Linked Report).   Reporter did not allow further contact; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-728837:Master case patient no. 01
Age: 18.0
Sex: M
Vaccine: COVID19-2
Symptoms: No adverse event, Wrong product administered
Clinical narrative: No adverse event; Moderna Bivalent COVID-19 vaccine with a pink cap instead of the Blue Cap; This spontaneous case was reported by a patient family member or friend and describes the occurrence of WRONG PRODUCT ADMINISTERED (Moderna Bivalent COVID-19 vaccine with a pink cap instead of the Blue Cap) and NO ADVERSE EVENT (No adverse event) in an 18-month-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. ASKU) for COVID-19 prophylaxis.     No Medical History information was reported.    In May 2023, the patient received first dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. In May 2023, the patient experienced WRONG PRODUCT ADMINISTERED (Moderna Bivalent COVID-19 vaccine with a pink cap instead of the Blue Cap). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (Moderna Bivalent COVID-19 vaccine with a pink cap instead of the Blue Cap) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (Moderna Bivalent COVID-19 vaccine with a pink cap instead of the Blue Cap).    Concomitant medication not reported.  Treatment medication not reported.
Age: 81.0
Sex: U
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event
Clinical narrative: No adverse event; I believe a single dose of Moderna bivalent vaccine was administered after expiration date.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (I believe a single dose of Moderna bivalent vaccine was administered after expiration date.) and NO ADVERSE EVENT (No adverse event) in an 81-year-old patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 069H22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 19-Jun-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 19-Jun-2023,  after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced EXPIRED PRODUCT ADMINISTERED (I believe a single dose of Moderna bivalent vaccine was administered after expiration date.). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (I believe a single dose of Moderna bivalent vaccine was administered after expiration date.) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (I believe a single dose of Moderna bivalent vaccine was administered after expiration date.).    No concomitant information was reported. Suspect product dosage text was reported as unknown. No treatment information was provided.
Age: 48.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fine motor skill dysfunction, Hypoaesthesia, Impaired quality of life, Incontinence, Magnetic resonance imaging abnormal
Clinical narrative: Two days after the administration of the second dose, I started not to be able to move my neck to the left. I had an MRI and was diagnosed with cervical spondylosis. In May 2023, started feeling extreme numbeness (pins and needles) on both my arms and fingers. I have tingling sensations on my whole arms and my fingers are shaky. My fine motor skills have deteriorated a lot and have problems with incontinence. My doctor suspects that my cervical spondylosis has progressed to the incurable disease of cervical myelopathy. I will have another MRI scan this week to confirm it.  My life has changed completely as the quality of my life is deteriorating after being vaccinated.
Age: 48.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Magnetic resonance imaging neck, Mobility decreased, Myelopathy, Paraesthesia, Spinal osteoarthritis
Clinical narrative: Two days after the administration of the second dose, I started not to be able to move my neck to the left. I had an MRI and was diagnosed with cervical spondylosis. In May 2023, started feeling extreme numbeness (pins and needles) on both my arms and fingers. I have tingling sensations on my whole arms and my fingers are shaky. My fine motor skills have deteriorated a lot and have problems with incontinence. My doctor suspects that my cervical spondylosis has progressed to the incurable disease of cervical myelopathy. I will have another MRI scan this week to confirm it.  My life has changed completely as the quality of my life is deteriorating after being vaccinated.
Age: 48.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Tremor
Clinical narrative: Two days after the administration of the second dose, I started not to be able to move my neck to the left. I had an MRI and was diagnosed with cervical spondylosis. In May 2023, started feeling extreme numbeness (pins and needles) on both my arms and fingers. I have tingling sensations on my whole arms and my fingers are shaky. My fine motor skills have deteriorated a lot and have problems with incontinence. My doctor suspects that my cervical spondylosis has progressed to the incurable disease of cervical myelopathy. I will have another MRI scan this week to confirm it.  My life has changed completely as the quality of my life is deteriorating after being vaccinated.
Sex: F
Vaccine: COVID19
Symptoms: Musculoskeletal disorder
Clinical narrative: Took government mandated Covid vaccine and lost all use below the waist.
Age: 80.0
Sex: M
Vaccine: COVID19-2
Symptoms: Headache, Musculoskeletal stiffness, Pyrexia
Clinical narrative: Stiff upper arms, back, thighs & back (Salonpas helped the back). Then developed headache & fever for 4 days after taking Moderna Bivalent Booster for Covid 19.
Sex: F
Vaccine: VARZOS
Symptoms: Diarrhoea, Pain in extremity, Vomiting
Clinical narrative: Patient received second dose of her Shingles series and she stated that she had a very sore arm, starting 12 hours after vaccine, as well as vomiting and diarrhea. Patient stated she had a sore arm 2 days after, and asked we report incident. Pt stated she did not feel the above after her first Shingles vaccine. Shingles vaccine in the suggested 2-6 month interval.
Age: 67.0
Sex: F
Vaccine: COVID19-2
Symptoms: Sleep apnoea syndrome, Symptom recurrence
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE SLEEP APNEA 11/19/2022 &  11/16/2022  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 73.0
Sex: F
Vaccine: COVID19-2
Symptoms: Chronic respiratory failure, Respiratory failure
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE CHRONIC HYPOXEMIC RESPIRATORY FAILURE
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Hypotension
Clinical narrative: HYPOTENSION
Age: 79.0
Sex: M
Vaccine: PNC13
Symptoms: Wrong product administered
Clinical narrative: Patient thought he was getting a Prevnar 20 but he actually got a Prevnar 13
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Aptyalism, COVID-19, Ear congestion, Ear discomfort, Hypoacusis
Clinical narrative: I did not have an adverse reaction to the vaccine. In 03/2023, my ears became congested. I had an outer ear infection and got treatment for that, but it didn't help with the congestion. I went to an ENT and got treated for the congestion, but it still hasn't gone away. I was diagnosed with salivary glands are plugged and my ears are plugged. As of today, I have very little salivary, and my hearing has not improved. I am following up with my doctor soonest. I previously tested positive twice in 2022. First was in 05/2022 and I lost my sense of smell. Second time was 10/2022, I felt really sick.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Malaise, Otitis externa, SARS-CoV-2 test positive, Salivary gland disorder
Clinical narrative: I did not have an adverse reaction to the vaccine. In 03/2023, my ears became congested. I had an outer ear infection and got treatment for that, but it didn't help with the congestion. I went to an ENT and got treated for the congestion, but it still hasn't gone away. I was diagnosed with salivary glands are plugged and my ears are plugged. As of today, I have very little salivary, and my hearing has not improved. I am following up with my doctor soonest. I previously tested positive twice in 2022. First was in 05/2022 and I lost my sense of smell. Second time was 10/2022, I felt really sick.
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: Transient ischaemic attack
Clinical narrative: TRANSIENT CEREBRAL ISCHEMIA
Age: 89.0
Sex: M
Vaccine: PNC13
Symptoms: Wrong product administered
Clinical narrative: Patient believed to get a Prevnar 20 but got a Prevnar 13 instead
Age: 80.0
Sex: F
Vaccine: PNC13
Symptoms: Wrong product administered
Clinical narrative: Patient believed to get a Prevnar 20 but got a Prevnar 13 instead
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Hypotension
Clinical narrative: HYPOTENSION
Age: 1.17
Sex: M
Vaccine: COVID19
Symptoms: Hypoxia
Clinical narrative: HYPOXIA
Age: 65.0
Sex: F
Vaccine: PNC13
Symptoms: Wrong product administered
Clinical narrative: Patient thought they were getting a Prevnar 20 but got Prevnar 13 instead
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Ischaemic stroke
Clinical narrative: ACUTE STROKE DUE TO ISCHEMIA, UNSPECIFIED TYPE AND ARTERY
Age: 86.0
Sex: F
Vaccine: PNC13
Symptoms: Wrong product administered
Clinical narrative: Patient thought they were getting a Prevnar 20  but got a Prevnar 13 instead
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Chronic respiratory failure, Respiratory failure
Clinical narrative: ACUTE RESPIRATORY FAILURE ACUTE HYPOXEMIC RESPIRATORY FAILURE CHRONIC RESPIRATORY FAILURE CHRONIC HYPOXEMIC RESPIRATORY FAILURE ACUTE ON CHRONIC HYPERCAPNIC RESPIRATORY FAILURE
Age: 74.0
Sex: F
Vaccine: COVID19-2, COVID19
Symptoms: Death
Clinical narrative: pt found expired in bed the next day
Age: 75.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, Malaise, Oropharyngeal pain, Pain in extremity, SARS-CoV-2 test positive
Clinical narrative: I had a sore arm for about a day after receiving the vaccine.  I started feeling sick on 06/16/2023 with a sore throat thinking it was a cold. On 06/18/2023, I tested positive for COVID-19. I contacted my doctor and got a prescription for Paxlovid. I felt better after taking the first dose but it tastes terrible.
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 2 vaccines Pfizer 3/17/21 lot# ER2613;  Pfizer 4/7/21 lot# ER2613
Age: 72.0
Sex: M
Vaccine: PNC13
Symptoms: Wrong product administered
Clinical narrative: Patient given a Prevnar 13 and not a Prevnar 20 as they thought they were getting
Age: 91.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 2 vaccines Pfizer 3/10/21 lot# EN6207;  Pfizer 3/31/21 lot# ER8734
Age: 0.5
Sex: F
Vaccine: RV5
Symptoms: Crying, Differential white blood cell count, Full blood count, Intussusception, Metabolic function test
Clinical narrative: First symptoms started 6/20/2023 early in the morning. Patient started screaming and crying inconsolable. Mom took patient to ER to be evaluated and she vomited once there. ER sent patient home without imaging or testing. Mom states that vomiting continued all throughout the day and she took her back to the ER 06/21/2023 at 1230AM for vomiting and bleeding from rectum. Pt was dx with intussusception. It was fixed and patient is currently still in ER being observed.
Age: 0.5
Sex: F
Vaccine: RV5
Symptoms: Rectal haemorrhage, Screaming, Vomiting
Clinical narrative: First symptoms started 6/20/2023 early in the morning. Patient started screaming and crying inconsolable. Mom took patient to ER to be evaluated and she vomited once there. ER sent patient home without imaging or testing. Mom states that vomiting continued all throughout the day and she took her back to the ER 06/21/2023 at 1230AM for vomiting and bleeding from rectum. Pt was dx with intussusception. It was fixed and patient is currently still in ER being observed.
Age: 32.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Exercise tolerance decreased, Impaired work ability, Pyrexia, Vision blurred
Clinical narrative: I had a fever of 103 and was unable to work.  I had blurred vision and could not find the wrung on my beds ladder to get out of bed, I was working at the time.  I had weakness for months afterwards and lost almost a minute on my mile and a half PT run.
Age: 97.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 3 vaccines Pfizer 3/29/21 Lot# ER8730;  Pfizer 4/23/21 lot# Ew0172;  Pfizer 3/6/22 lot# FK9895
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 3 vaccines Pfizer 3/29/21 Lot# ER8730;  Pfizer 4/23/21 lot# Ew0172;  Pfizer 3/6/22 lot# FK9895
Age: 55.0
Sex: F
Vaccine: COVID19-2
Symptoms: Acute myocardial infarction, Angina unstable, Symptom recurrence
Clinical narrative: UNSTABLE ANGINA ACUTE NON ST ELEVATION MI ACUTE MI 12/14/2022  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 95.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: COVID +
Age: 66.0
Sex: M
Vaccine: PNC13
Symptoms: Wrong product administered
Clinical narrative: Patient thought they were getting a prevnar 20 but got a prevnar 13 instead
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 4 vaccines Moderna 2/25/21 lot# 031M20A;  Moderna 3/25/21 lot# 045A21A;  Moderna 12/7/21 lot# 045J21A;  Moderna 5/17/22 lot# 056M21A
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Discharge, Lymph node pain, Nasal congestion, Pneumonia bacterial
Clinical narrative: I had severe nasal congestion, throat drainage, achy and tender glands. I also was coughing and was congested with sneezing.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Respiratory tract congestion, Sinusitis, Sneezing
Clinical narrative: I had severe nasal congestion, throat drainage, achy and tender glands. I also was coughing and was congested with sneezing.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 3 vaccines Pfizer 3/20/21 lot# EP7534;  Pfizer 4/10/21 lot# EW0161;  Pfizer 11/13/21 lot# FH8030
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 2 vaccines Pfizer 3/8/21 lot# EN6202;  Pfizer 3/29/21 lot# ER2613
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Acute myocardial infarction
Clinical narrative: ACUTE NON ST ELEVATION MI
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 2 vaccines Pfizer 1/12/22 lot# FJ1614;  Pfizer 2/1/22 lot# FJ1614
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 3 vaccines  Pfizer 1/18/21 lot# EL3249;  Pfizer 2/8/21 lot# EL9265;  Pfizer 10/14/21 lot# FF8841
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 3 vaccines Pfizer 1/18/21  lot# EL3249;  Pfizer 2/8/21 lot# EL9265;  Pfizer 10/14/21 lot# FF8841
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 2 vaccines Pfizer 1/28/21 lot# EL9265; Pfizer 2/18/21 lot# EN6200
Age: 81.0
Sex: M
Vaccine: COVID19-2
Symptoms: Acute myocardial infarction, Angina pectoris, Angina unstable
Clinical narrative: UNSTABLE ANGINA ANGINA, UNSPECIFIED ACUTE NON ST ELEVATION MI
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 2 vaccines Pfizer 7/21/21 lot# FA6780;  Pfizer 8/1/21 lot# FC3180
Age: 81.0
Sex: M
Vaccine: COVID19-2
Symptoms: Arthralgia, Chondrocalcinosis, Pain, Pain in jaw, Swelling
Clinical narrative: I did not have an adverse reaction to the vaccine. On 04/21/2023, I developed pain in my jaw in the left joint. The pain was not due to dental issues, but I was diagnosed with TMJ. When I was young, I had an injury to my jaw that caused it to be very sore for a day. I do have a history kidney function issue. I have joint pain and swelling on my left and side of my body.  I was diagnosed with pseudogout.  I am taking steroids for the pain and swelling.  Also, I tested positive for COVID-19 in 10/2022 and I took Paxlovid to help with my symptoms. As of today, everything is back to normal.
Age: 81.0
Sex: M
Vaccine: COVID19-2
Symptoms: Temporomandibular joint syndrome
Clinical narrative: I did not have an adverse reaction to the vaccine. On 04/21/2023, I developed pain in my jaw in the left joint. The pain was not due to dental issues, but I was diagnosed with TMJ. When I was young, I had an injury to my jaw that caused it to be very sore for a day. I do have a history kidney function issue. I have joint pain and swelling on my left and side of my body.  I was diagnosed with pseudogout.  I am taking steroids for the pain and swelling.  Also, I tested positive for COVID-19 in 10/2022 and I took Paxlovid to help with my symptoms. As of today, everything is back to normal.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 3 vaccines Moderna 3/7/21 lot 015M20A; Moderna 4/5/21 lot 025B21A; Moderna 9/11/21 lot 045C21A.
Age: 79.0
Sex: F
Vaccine: VARZOS
Symptoms: Blood lactic acid increased, Chest X-ray normal, Chills, Dehydration, Diarrhoea
Clinical narrative: Patient came into Health Department on 06/06/2023 for her 2nd shingles vaccine. Patient was asked how she did with her first shingles vaccine that was given on 03/14/2023. Patient reported she did well and had no reactions. Administered shingles vaccine in left deltoid at 1232. Patient thanked me and left the health department. On 06/13/2023 I received a phone call from patients PCP stating patient was seen in the ER and patient thinks it was due to 2nd shingles vaccine. Patient reported her symptoms were vomiting, fever, chills, diarrhea, and blacking out. Patient?s husband called an ambulance for her. My immunization supervisor got patients ER notes faxed to us. Patient was seen in the ER on 06/07/2023 at 0719. Arrived by ambulance and chief complaint was nausea and vomiting. Patient denies SOB, chest pain, diarrhea, constipation, fever, and chills. EKG was done and no NSR was shown. Chest x-ray shows no wide mediastinum, pneumothorax, or pneumonia. Labs were drawn. Lactic acid is minimally elevated due to mild dehydration. CMP showed signs of mild dehydration. IV fluids were started. At 0915 patient reported significant improvement of her nausea and vomiting. She feels significantly better after IV fluids and is requesting to be discharged. Patient was discharged and was told to follow up with PCP in 2-3 days. Report of follow up was given to RN supervisor of the immunization department. Patient is reported to be doing better.
Age: 79.0
Sex: F
Vaccine: VARZOS
Symptoms: Electrocardiogram normal, Laboratory test abnormal, Loss of consciousness, Metabolic function test abnormal, Nausea
Clinical narrative: Patient came into Health Department on 06/06/2023 for her 2nd shingles vaccine. Patient was asked how she did with her first shingles vaccine that was given on 03/14/2023. Patient reported she did well and had no reactions. Administered shingles vaccine in left deltoid at 1232. Patient thanked me and left the health department. On 06/13/2023 I received a phone call from patients PCP stating patient was seen in the ER and patient thinks it was due to 2nd shingles vaccine. Patient reported her symptoms were vomiting, fever, chills, diarrhea, and blacking out. Patient?s husband called an ambulance for her. My immunization supervisor got patients ER notes faxed to us. Patient was seen in the ER on 06/07/2023 at 0719. Arrived by ambulance and chief complaint was nausea and vomiting. Patient denies SOB, chest pain, diarrhea, constipation, fever, and chills. EKG was done and no NSR was shown. Chest x-ray shows no wide mediastinum, pneumothorax, or pneumonia. Labs were drawn. Lactic acid is minimally elevated due to mild dehydration. CMP showed signs of mild dehydration. IV fluids were started. At 0915 patient reported significant improvement of her nausea and vomiting. She feels significantly better after IV fluids and is requesting to be discharged. Patient was discharged and was told to follow up with PCP in 2-3 days. Report of follow up was given to RN supervisor of the immunization department. Patient is reported to be doing better.
Age: 79.0
Sex: F
Vaccine: VARZOS
Symptoms: Pyrexia, Sinus rhythm, Vomiting
Clinical narrative: Patient came into Health Department on 06/06/2023 for her 2nd shingles vaccine. Patient was asked how she did with her first shingles vaccine that was given on 03/14/2023. Patient reported she did well and had no reactions. Administered shingles vaccine in left deltoid at 1232. Patient thanked me and left the health department. On 06/13/2023 I received a phone call from patients PCP stating patient was seen in the ER and patient thinks it was due to 2nd shingles vaccine. Patient reported her symptoms were vomiting, fever, chills, diarrhea, and blacking out. Patient?s husband called an ambulance for her. My immunization supervisor got patients ER notes faxed to us. Patient was seen in the ER on 06/07/2023 at 0719. Arrived by ambulance and chief complaint was nausea and vomiting. Patient denies SOB, chest pain, diarrhea, constipation, fever, and chills. EKG was done and no NSR was shown. Chest x-ray shows no wide mediastinum, pneumothorax, or pneumonia. Labs were drawn. Lactic acid is minimally elevated due to mild dehydration. CMP showed signs of mild dehydration. IV fluids were started. At 0915 patient reported significant improvement of her nausea and vomiting. She feels significantly better after IV fluids and is requesting to be discharged. Patient was discharged and was told to follow up with PCP in 2-3 days. Report of follow up was given to RN supervisor of the immunization department. Patient is reported to be doing better.
Age: 93.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 3 vaccines Moderna 1/21/21 lot# 012L20A;  Moderna 2/18/21 lot# 004M20A;  Moderna 11/23/21 lot# 004M20A
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: COVID vaccine breakthrough case. Pfizer 3/5/21 EN6202, 3/26/2021 EN6207 and 11/15/21 FH8030
Age: 16.0
Sex: F
Vaccine: TDAP
Symptoms: No adverse event, Wrong product administered
Clinical narrative: Pt was supposed to receive a Menquadfi vaccine per the provider's order on 6/2/23 at 2pm. But the pt received an Adacel vaccine. There are no reported adverse signs or symptoms at this time.
Age: 47.0
Sex: F
Vaccine: COVID19-2
Symptoms: Acute respiratory failure, COVID-19, COVID-19 pneumonia, Cough, Death
Clinical narrative: The patient has a history of rheumatoid arthritis. She was brought to the Hospital ED by EMS on 4/22/23 with diarrhea and dizziness. She has had continuous loose stools and vomiting since 4/1/23. She had been evaluated at an outside ED and clinic previously, however returned to the ED due to persistent diarrhea, nausea, cough, fever, and dizziness. She was admitted 4/22/23. On day of admission, she tested positive for COVID by PCR. Notably, she previously tested positive in February 2023; she reports she tested negative following this episode of illness. During admission she did require supplemental oxygen up to 15L O2.  She was treated empirically for possible bacterial pneumonia. On 5/2/23 she was transferred from this Hospital to a different Hospital due to need for bronchoscopy. On 5/4/23, the patient had worsening oxygenation which prompted eventual transfer to the ICU and treatment with BiPAP. She suddenly worsened on 5/7/23 and was intubated. Following this, she developed nonperfusing ventricular arrhythmias - CPR was done, however the patient did not survive and passed away 5/7/23. Discharge diagnoses included COVID infection with pneumonitis and acute hypoxic respiratory failure, among other diagnoses.
Age: 47.0
Sex: F
Vaccine: COVID19-2
Symptoms: Diarrhoea, Dizziness, Endotracheal intubation, Illness, Intensive care
Clinical narrative: The patient has a history of rheumatoid arthritis. She was brought to the Hospital ED by EMS on 4/22/23 with diarrhea and dizziness. She has had continuous loose stools and vomiting since 4/1/23. She had been evaluated at an outside ED and clinic previously, however returned to the ED due to persistent diarrhea, nausea, cough, fever, and dizziness. She was admitted 4/22/23. On day of admission, she tested positive for COVID by PCR. Notably, she previously tested positive in February 2023; she reports she tested negative following this episode of illness. During admission she did require supplemental oxygen up to 15L O2.  She was treated empirically for possible bacterial pneumonia. On 5/2/23 she was transferred from this Hospital to a different Hospital due to need for bronchoscopy. On 5/4/23, the patient had worsening oxygenation which prompted eventual transfer to the ICU and treatment with BiPAP. She suddenly worsened on 5/7/23 and was intubated. Following this, she developed nonperfusing ventricular arrhythmias - CPR was done, however the patient did not survive and passed away 5/7/23. Discharge diagnoses included COVID infection with pneumonitis and acute hypoxic respiratory failure, among other diagnoses.
Age: 47.0
Sex: F
Vaccine: COVID19-2
Symptoms: Nausea, Positive airway pressure therapy, Pyrexia, Resuscitation, SARS-CoV-2 test positive
Clinical narrative: The patient has a history of rheumatoid arthritis. She was brought to the Hospital ED by EMS on 4/22/23 with diarrhea and dizziness. She has had continuous loose stools and vomiting since 4/1/23. She had been evaluated at an outside ED and clinic previously, however returned to the ED due to persistent diarrhea, nausea, cough, fever, and dizziness. She was admitted 4/22/23. On day of admission, she tested positive for COVID by PCR. Notably, she previously tested positive in February 2023; she reports she tested negative following this episode of illness. During admission she did require supplemental oxygen up to 15L O2.  She was treated empirically for possible bacterial pneumonia. On 5/2/23 she was transferred from this Hospital to a different Hospital due to need for bronchoscopy. On 5/4/23, the patient had worsening oxygenation which prompted eventual transfer to the ICU and treatment with BiPAP. She suddenly worsened on 5/7/23 and was intubated. Following this, she developed nonperfusing ventricular arrhythmias - CPR was done, however the patient did not survive and passed away 5/7/23. Discharge diagnoses included COVID infection with pneumonitis and acute hypoxic respiratory failure, among other diagnoses.
Age: 47.0
Sex: F
Vaccine: COVID19-2
Symptoms: Ventricular arrhythmia, Vomiting
Clinical narrative: The patient has a history of rheumatoid arthritis. She was brought to the Hospital ED by EMS on 4/22/23 with diarrhea and dizziness. She has had continuous loose stools and vomiting since 4/1/23. She had been evaluated at an outside ED and clinic previously, however returned to the ED due to persistent diarrhea, nausea, cough, fever, and dizziness. She was admitted 4/22/23. On day of admission, she tested positive for COVID by PCR. Notably, she previously tested positive in February 2023; she reports she tested negative following this episode of illness. During admission she did require supplemental oxygen up to 15L O2.  She was treated empirically for possible bacterial pneumonia. On 5/2/23 she was transferred from this Hospital to a different Hospital due to need for bronchoscopy. On 5/4/23, the patient had worsening oxygenation which prompted eventual transfer to the ICU and treatment with BiPAP. She suddenly worsened on 5/7/23 and was intubated. Following this, she developed nonperfusing ventricular arrhythmias - CPR was done, however the patient did not survive and passed away 5/7/23. Discharge diagnoses included COVID infection with pneumonitis and acute hypoxic respiratory failure, among other diagnoses.
Age: 1.67
Sex: M
Vaccine: HEPA, PNC15, TDAP
Symptoms: Wrong product administered
Clinical narrative: Pt given Tdap when a Dtap was ordered.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Transient ischaemic attack
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE TRANSIENT CEREBRAL ISCHEMIA
Age: 71.0
Sex: F
Vaccine: COVID19-2
Symptoms: Unevaluable event
Clinical narrative: none
Age: 51.0
Sex: F
Vaccine: COVID19-2
Symptoms: Acute myocardial infarction
Clinical narrative: ACUTE NON ST ELEVATION MI
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Pulmonary embolism, Symptom recurrence
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE ACUTE PULMONARY EMBOLISM 12/3/2022 -- RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 2.0
Sex: F
Vaccine: DTAP, HEP
Symptoms: Extra dose administered, No adverse event
Clinical narrative: Patient received inadvertent extra dose of vaccines above.  No physical side effects were reported.
Age: 1.0
Sex: F
Vaccine: MMRV
Symptoms: No adverse event, Wrong product administered
Clinical narrative: Patient was given ProQuad instead of the ordered MMR II.  No know adverse reactions.
Age: 67.0
Sex: M
Vaccine: COVID19-2
Symptoms: Acute myocardial infarction, Hypotension
Clinical narrative: ACUTE ST ELEVATION MI, ANTERIOR WALL ACUTE ST ELEVATION MI, UNSPECIFIED TRANSIENT HYPOTENSION
Age: 53.0
Sex: F
Vaccine: HEP
Symptoms: Underdose
Clinical narrative: The patient received a state supply (pediatric) vaccine instead of a private supply (adult) dose of Engerix-B
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Nodular lymphocyte predominant Hodgkin lymphoma, Obstructive sleep apnoea syndrome
Clinical narrative: G47.33 OBSTRUCTIVE SLEEP APNEA 3/6/2023 HODGKIN NODULAR LYMPHOCYTE PREDOMINANT LYMPHOMA, UNSPECIFIED SITE
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Bronchitis, Chest X-ray, Cough, Loss of personal independence in daily activities, Sleep disorder
Clinical narrative: I have a dry cough no product or nothing comes up but it is enough to interrupt conversation , sleep, and daily activities. I was prescribed Cefdinir.